Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-03-07
2006-03-07
Wilson, James O. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
active
07008944
ABSTRACT:
Compounds of the formula:are useful for the treatment of depression and other diseases such as obsessive compulsive disorder, panic attacks, generalized anxiety disorder, social anxiety disorder, sexual dysfunction, eating disorders, obesity, addictive disorders caused by ethanol or cocaine abuse and related illnesses.
REFERENCES:
patent: 5318988 (1994-06-01), Schohe-Loop et al.
patent: 5371094 (1994-12-01), Heine et al.
patent: 5741789 (1998-04-01), Hibschman et al.
patent: 5756532 (1998-05-01), Stack et al.
patent: 5869490 (1999-02-01), Stack
patent: 0 771 800 (1997-05-01), None
patent: WO 91/13872 (1991-09-01), None
patent: WO 97/23485 (1997-07-01), None
Crow and Mitchell, “Rational Therapy of Eating Disorders” Drugs, vol. 48(3), pp. 372-379 (1994).
Monteljo-Gonzales et al, “SSRI-Induced Sexual Dysfunction: Fluoxetine, Paroxetine, Sertraline, and Fluvoxamine in a Prospective, Multicenter, and Descriptive Clinical Study of 344 Patients” J. Sex and Marital Therapy, vol. 23(3), pp. 176-194 (Fall 1997).
Gorman and Kent, “SSRIs and SNRIs: Broad Spectrum of Efficacy Beyond Major Depression” J. Clin. Psychiatry, vol. 60(suppl 4), pp. 33-39 (1999).
Rosen et al, “Effects of SSRIs on Sexual Function: A Critical Review” J. Clin. Psychopharmacology, vol. 19(1), pp. 67-85 (1999).
Berendsen, “The role of serotonin in hot flushes” Maturitas, vol. 36, pp. 155-164 (2000).
Lima et al, “Antidepressants for Cocaine Dependence.” The Cochrane Database of Systematic Reviews, issue 2, article No. CD002950 (2003).
Naranjo and Knoke, “The Role of Serotonin Reuptake Inhibitors in Reducing Alcohol Consumption” J. Clin. Psychiatry, vol. 62(suppl. 20), pp. 18-25 (2001).
Boyer, W. F. “Potential Indications for the Selective Serotonin Reuptake Inhibitors” International Journal of Psychopharmacology, vol. 6(suppl. 5), pp. 5-12 (1992).
Pallanti et al, “Citalopram in Anorexia Nervosa” Eating & Weight Disorders, vol. 2(4), pp. 216-221 (1997).
Fassino et al, “Efficacy of Citalopram in Anorexia Nervosa: a Pilot Study” European Neuropsychopharmacology, vol. 12, pp. 453-459 (2002).
Robichaud et al., Annual Reports in Med. Chem., 2000, 11-20, 35.
Wyatt et al., Abstract for Cochrane Database of Systemic Reviews, 2002, CD001396.
Martenyi et al., Abstract for J. Clin. Psychiatry, Mar. 2002, 199-206, 63(3).
Rushton et al., Abstract for Pediatrics, Jun. 2000, p. E82, 105(6).
Sundstrom-Poromaa et al., Abstract for J. Psychosom. Obstet. Gynaecol, Dec. 2000, 205-211, 21.
Gross Jonathan L.
Stack Gary P.
Tucker Zachary C.
Wilson James O.
Woodcock & Washburn LLP
Wyeth
LandOfFree
Antidepressant azaheterocyclylmethyl derivatives of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antidepressant azaheterocyclylmethyl derivatives of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antidepressant azaheterocyclylmethyl derivatives of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3579689